![Agnete Brunsvik Fredriksen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Agnete Brunsvik Fredriksen
Gründer bei
NYKODE THERAPEUTICS
Vermögen: 22 033 $ am 30.09.2026
Profil
Agnete Brunsvik Fredriksen is the founder of Nykode Therapeutics ASA, established in 2006, serving as Chief Scientific Officer since 2024.
Current jobs include Independent Non-Executive Director at Molecular Partners AG since 2021 and Director at Viginti AS.
Former jobs include Director-Life Science at the University of Oslo, Researcher at Medinnova AS, and Researcher at Affitech A. Education history includes graduate and doctorate degrees from the University of Oslo, with the doctorate conferred in 2007.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
MOLECULAR PARTNERS AG 0,01 % | 31.12.2025 | 5.541 ( 0,01 % ) | 22 033 $ | 30.09.2026 |
Aktive Positionen von Agnete Brunsvik Fredriksen
| Unternehmen | Position | Beginn |
|---|---|---|
| NYKODE THERAPEUTICS | Gründer | 22.11.2006 |
| MOLECULAR PARTNERS AG | Direktor/Vorstandsmitglied | 21.04.2021 |
Viginti AS | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Agnete Brunsvik Fredriksen
| Unternehmen | Position | Ende |
|---|---|---|
Affitech A/S
 Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Corporate Officer/Principal | - |
University of Oslo
 University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | - |
Medinnova AS
 Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees. | Corporate Officer/Principal | - |
Ausbildung von Agnete Brunsvik Fredriksen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
74
Beziehungen ersten Grades
6
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
Medinnova AS
Medinnova AS Investment ManagersFinance Medinnova's investment strategy focuses on developing commercial projects in the areas of biomedicine and health care. They work closely with entrepreneurs and public health care employers to develop ideas, evaluate viability of novel inventions, secure intellectual rights for a patent or protection, assist with product development, prepare business plans, and support applications for public funding. The firm is an active investment partner for the establishment of new firms. They provide access to their network of industry expertise, work cohesively with the public policy system, and negotiate with investors and licensees in addition to following-up with licensees. | Finance |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
Affitech A/S
Affitech A/S Pharmaceuticals: MajorHealth Technology Researches and develops human antibody therapeutics | Health Technology |
Viginti AS |
